Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2023-08-01
2023-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Some of these reactions, such as increased blood perfusion, are known to be related to the increase in temperature, but others, such as increased cell proliferation, appear to be primarily related to the passage of current.
It is also true that this increase in tissue temperature, generated through the application of the device, is a physical reaction to the passage of current (Joule effect). Although there is already clinical literature supporting this mechanism, the amount of energy and current that must be transferred to obtain the desired temperature rise is unknown. Moreover, the control of these reactions, by adjusting parameters such as absorbed power and electrode position, is still largely based on the empirical experience of therapists .
Recently, new cadaveric publications have been generated, which support the mechanisms of current flow and thermal changes in this situation.
Against this background, in which thermal effects, current passage and symptomatic improvements have been demonstrated in patients with pathology, the possibility that these treatments may improve functional sporting abilities is raised. This hypothesis arises from the fact that current flow and thermal changes have been directly related to viscoelastic changes in capsular and muscle tissue.
To date, there is no study that has assessed whether this therapy generates any change in functional variables related to sports performance in professional athletes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Energy Transfer Therapy in Treatment of Medial Gastrocnemius
NCT04325750
Capacitive Resistive Electric Transfer Therapy on Muscle Recovery
NCT06906146
Light Therapy and Electrical Stimulation on Functional Performance in Volleyball Athletes
NCT02443701
Electrotherapy and Myofascial Therapy in Padel Players
NCT03867292
Effectiveness of the "Tecaretherapy" in Patients With Lateral Elbow Tendinopathy
NCT03939247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Some of these reactions, such as increased blood perfusion, are known to be related to the increase in temperature, but others, such as increased cell proliferation, appear to be primarily related to the passage of current.
It is also true that this increase in tissue temperature, generated through the application of the device, is a physical reaction to the passage of current (Joule effect). Although there is already clinical literature supporting this mechanism, the amount of energy and current that must be transferred to obtain the desired temperature rise is unknown. Moreover, the control of these reactions, by adjusting parameters such as absorbed power and electrode position, is still largely based on the empirical experience of therapists .
Recently, new cadaveric publications have been generated, which support the mechanisms of current flow and thermal changes in this situation.
Against this background, in which thermal effects, current passage and symptomatic improvements have been demonstrated in patients with pathology, the possibility that these treatments may improve functional sporting abilities is raised. This hypothesis arises from the fact that current flow and thermal changes have been directly related to viscoelastic changes in capsular and muscle tissue.
To date, there is no study that has assessed whether this therapy generates any change in functional variables related to sports performance in professional athletes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tecartherpay Group
A single 25-minute tecartherapy procedure will be performed in both legs with the T-Plus Wintecare® machine. The configuration of the tecartherapy programme will be in 40 watts resistive mode for each muscle.
Tecartherapy
The tecartherapy intervention was with a deep diathermy machine applied to the patient's lower extremity for 30 minutes.
Sham group
The same procedure of the intervention group will be performed but with the tecartherapy machine without power (sham). The machine will be on but no power will be supplied.
Tecartherapy
The tecartherapy intervention was with a deep diathermy machine applied to the patient's lower extremity for 30 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tecartherapy
The tecartherapy intervention was with a deep diathermy machine applied to the patient's lower extremity for 30 minutes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active participation in regional, national or international competitions.
* Study participants must have signed the informed consent form in order to evaluate their inclusion in the study.
Exclusion Criteria
* Not understanding the information provided by the therapist.
* Participate in other research studies.
* Being under a pharmacological medical treatment that may interfere with the measures, such as treatment with anticonvulsants, antidepressants, etc.
18 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Maxim Canet Vintró
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maxim Canet Vintró
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitat Internacional de Catalunya
Sant Cugat del Vallès, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CBAS-2021-08
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.